Market Outlook
The global Mesalamine market size was valued at USD 161 million in 2022 and is forecast to a readjusted size of USD 198.9 million by 2029 with a CAGR of 3.1% during review period.
Mesalamine, also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The industry's leading manufacturers are Syntese A/S, Divis Laboratories, ipca Laboratories and Cambrex Corporation, which accounted for 23.74%, 14.71%, 6.44% and 6.35% of the global revenue share in 2019, respectively. In terms of regions, the revenue share of Europe is the highest, reaching 41.11% in 2019.
This report is a detailed and comprehensive analysis for global Mesalamine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Mesalamine market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Mesalamine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Mesalamine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Mesalamine market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mesalamine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mesalamine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Hangzhou Brother
PharmaZell
Lianyungang Fengheng Biopharm
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segmentation By Type
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%
Segmentation By Application
Mesalazine Tablets
Mesalazine Capsules
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Mesalamine market in 2025?
The Mesalamine market benefits from increasing awareness and the growing prevalence of inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease. Its ability to effectively treat these chronic conditions boosts its demand. Additionally, Mesalamine's established position in the treatment of IBD provides a strong market foundation.
What are the weaknesses of the Mesalamine market in 2025?
One weakness is the potential side effects, such as gastrointestinal disturbances, which could deter some patients from using Mesalamine. The market may also face challenges from generic competitors, leading to price pressures and reduced profit margins for brand-name drugs. Limited innovation in drug formulations can restrict market growth.
What opportunities exist in the Mesalamine market in 2025?
Opportunities in the Mesalamine market include the development of new formulations, such as extended-release or combination therapies, which could enhance patient compliance and treatment effectiveness. Expanding in emerging markets with growing healthcare access presents another opportunity. Moreover, increasing research into personalized medicine for IBD could drive demand for tailored Mesalamine treatments.
What are the threats to the Mesalamine market in 2025?
The major threats include the rising competition from biosimilars and other biologic therapies that offer improved efficacy for IBD patients. Price cuts from generics and increased regulatory scrutiny over drug approvals could also pose risks to Mesalamine's market share. Economic downturns may further limit patient access to medications, impacting sales.
Market PESTEL Analysis
What are the political factors affecting the Mesalamine market in 2025?
Political factors, including government regulations and policies related to healthcare reimbursement, can directly impact the affordability and accessibility of Mesalamine. Changes in healthcare policies, particularly in developed markets, may influence the pricing and market entry of new formulations. Additionally, political stability in key markets is essential for the smooth distribution of drugs.
How do economic factors influence the Mesalamine market in 2025?
Economic factors such as healthcare spending and the economic health of key markets significantly influence the Mesalamine market. In times of economic downturn, patients may have limited access to expensive medications, pushing them toward generic options. Conversely, higher disposable incomes and improved healthcare funding in emerging economies could lead to increased demand for Mesalamine.
What social factors impact the Mesalamine market in 2025?
Social factors, like the increasing awareness of inflammatory bowel diseases (IBD) and a shift toward healthier lifestyles, can drive the demand for effective treatments like Mesalamine. Rising patient advocacy and support communities for IBD also contribute to more people seeking treatment options. Furthermore, demographic shifts, such as an aging population, may increase the prevalence of conditions requiring Mesalamine.
How do technological factors shape the Mesalamine market in 2025?
Technological advancements in drug delivery systems, such as controlled-release formulations, are shaping the Mesalamine market. These innovations can improve patient compliance and efficacy of treatment. Additionally, the use of digital health technologies, like telemedicine, allows for better monitoring and management of IBD, further driving demand for Mesalamine as part of comprehensive treatment strategies.
What environmental factors affect the Mesalamine market in 2025?
Environmental factors, including sustainability and the environmental impact of pharmaceutical manufacturing, are becoming more important. Regulations around the disposal of pharmaceutical waste and the carbon footprint of production processes may affect the manufacturing and distribution of Mesalamine. The push for eco-friendly packaging and production methods could also influence market dynamics.
What legal factors are relevant to the Mesalamine market in 2025?
Legal factors, such as patent protection, intellectual property rights, and regulatory approvals, play a crucial role in shaping the Mesalamine market. Generic competition can arise once patents expire, leading to pricing pressure on branded Mesalamine products. Strict regulatory frameworks in different countries can also affect the speed and ease of market entry for new formulations of the drug.
Market SIPOC Analysis
Who are the suppliers in the Mesalamine market in 2025?
Suppliers in the Mesalamine market include raw material providers for the active pharmaceutical ingredient (API), such as chemical manufacturers. Pharmaceutical companies that produce the finished drug formulations and packaging suppliers also play a critical role. Additionally, suppliers of regulatory services and clinical research organizations contribute to the market.
Who are the inputs for the Mesalamine market in 2025?
Inputs for the Mesalamine market include the active ingredient Mesalamine, excipients, manufacturing technology, research and development (R&D) efforts, clinical trial data, and regulatory approvals. Market intelligence, such as epidemiological data on inflammatory bowel diseases (IBD), is also an important input for strategic planning.
What are the processes involved in the Mesalamine market in 2025?
The processes in the Mesalamine market involve drug formulation development, clinical testing, regulatory approval, manufacturing, marketing, and distribution. Ongoing post-market surveillance and feedback mechanisms ensure safety and efficacy. Additionally, patient education, healthcare provider training, and reimbursement processes are essential to product success.
Who are the customers in the Mesalamine market in 2025?
Customers in the Mesalamine market include healthcare providers, such as gastroenterologists and general practitioners, who prescribe the medication. Patients with inflammatory bowel diseases (IBD), specifically ulcerative colitis and Crohn’s disease, are the direct consumers of the product. Distributors, pharmacies, and hospitals also play a role in the customer chain.
What are the outputs of the Mesalamine market in 2025?
The outputs of the Mesalamine market include the finished Mesalamine products, in various formulations (e.g., tablets, capsules, and rectal forms), that are distributed to pharmacies, hospitals, and clinics. Additionally, the market produces customer support services, including patient education materials, as well as sales and clinical data to help guide future treatment decisions.
Market Porter's Five Forces
How strong is the threat of new entrants in the Mesalamine market in 2025?
The threat of new entrants in the Mesalamine market is moderate. While there are barriers to entry, such as high research and development costs, regulatory requirements, and established brand loyalty from existing players, the growing demand for IBD treatments and the potential for generic versions provide opportunities for new entrants, particularly in emerging markets.
How intense is the bargaining power of suppliers in the Mesalamine market in 2025?
The bargaining power of suppliers in the Mesalamine market is relatively low. The primary suppliers of active pharmaceutical ingredients (APIs) and other raw materials are numerous, leading to lower dependency on any single supplier. However, the complexity of obtaining regulatory approvals and maintaining quality standards can give certain specialized suppliers more influence.
How strong is the bargaining power of buyers in the Mesalamine market in 2025?
The bargaining power of buyers, including hospitals, pharmacies, and individual patients, is moderate to high. With the availability of generics and increasing price sensitivity, buyers can exert significant pressure, particularly on pricing and reimbursement policies. However, the effectiveness and critical need for Mesalamine in treating chronic conditions like IBD somewhat mitigate this power.
How high is the threat of substitute products in the Mesalamine market in 2025?
The threat of substitute products in the Mesalamine market is moderate. Biologic therapies and biosimilars are emerging as potential substitutes for Mesalamine, offering new treatment options for IBD patients. However, Mesalamine’s established track record and relatively lower cost compared to biologics help it retain its position in the market.
How competitive is the Mesalamine market in 2025?
The Mesalamine market is moderately competitive. While there are a few large players, generic versions of the drug and competition from biologic therapies increase rivalry. The market is also influenced by ongoing research for improved formulations and delivery systems. However, the critical need for effective treatments for IBD provides stability for key players.
Market Upstream Analysis
What are the key raw materials in the Mesalamine market in 2025?
The key raw materials in the Mesalamine market include the active pharmaceutical ingredient (API) Mesalamine, excipients, and chemical reagents used in the manufacturing process. Additionally, packaging materials, such as bottles, blister packs, and labels, are essential for the final product's distribution.
What are the critical suppliers in the upstream of the Mesalamine market in 2025?
Critical suppliers in the upstream of the Mesalamine market include chemical manufacturers that provide the raw materials for Mesalamine's synthesis, and the excipients used in formulations. Suppliers of manufacturing equipment and technologies also play an important role in ensuring efficient production. Additionally, suppliers of regulatory services that support clinical trials and product approval are vital.
How do regulations affect the upstream processes in the Mesalamine market in 2025?
Regulations have a significant impact on upstream processes. Stringent regulatory requirements related to Good Manufacturing Practices (GMP), safety standards, and environmental regulations affect the sourcing of raw materials and the production process. These regulations ensure quality and compliance but can also increase costs and production time for suppliers.
What challenges do upstream suppliers face in the Mesalamine market in 2025?
Upstream suppliers face challenges such as fluctuating raw material prices and supply chain disruptions, particularly for specialized chemicals required in the production of Mesalamine. They also deal with regulatory hurdles, which can delay production timelines and add to costs. Additionally, the growing demand for sustainable production practices is pushing suppliers to adopt eco-friendly methods.
What technological advancements are impacting the upstream of the Mesalamine market in 2025?
Technological advancements in production processes, such as automation in manufacturing and innovations in drug formulation, are influencing the upstream of the Mesalamine market. Advances in synthetic chemistry enable more efficient production of the active ingredient, while new technologies in packaging help reduce costs and improve sustainability.
Market Midstream Analysis
What are the key players involved in the midstream processes of the Mesalamine market in 2025?
Key players in the midstream processes of the Mesalamine market include pharmaceutical manufacturers who handle the bulk production of Mesalamine formulations. These players manage the quality control, packaging, and distribution to wholesalers, as well as those involved in clinical testing and regulatory approval. Logistics companies are also crucial in ensuring the drug reaches distribution points efficiently.
What are the major activities involved in the midstream of the Mesalamine market in 2025?
The major activities in the midstream include large-scale manufacturing of Mesalamine tablets, capsules, and other formulations, quality assurance and control, packaging, and the regulatory approval processes. Additionally, the distribution and storage of the final products at warehouses, wholesalers, and distributors are key activities in this segment.
How do regulations impact the midstream processes in the Mesalamine market in 2025?
Regulations play a vital role in the midstream processes by setting the standards for manufacturing, packaging, and labeling of Mesalamine products. Compliance with regulatory frameworks, such as FDA or EMA guidelines, ensures that the products meet safety and efficacy standards. This can affect production timelines, cost structures, and market entry for new formulations.
What challenges do companies face in the midstream of the Mesalamine market in 2025?
Companies face challenges such as maintaining consistent product quality across large-scale manufacturing, dealing with supply chain disruptions, and managing the complexities of global distribution networks. The need to comply with various regulatory requirements in different markets can also delay the time to market and increase costs. Furthermore, competition from generics puts pressure on profit margins.
What role does technology play in the midstream of the Mesalamine market in 2025?
Technology plays a crucial role in optimizing manufacturing processes, ensuring quality control, and improving supply chain efficiency. Automation in production lines reduces costs and enhances consistency in product quality. Additionally, digital tools for tracking inventory and managing distribution help streamline logistics, reducing delays and costs associated with the midstream processes.
Market Downstream Analysis
What are the key players in the downstream processes of the Mesalamine market in 2025?
Key players in the downstream processes of the Mesalamine market include pharmacies, healthcare providers (such as gastroenterologists), hospitals, and clinics that prescribe and dispense the medication. Additionally, insurance companies that provide reimbursement for Mesalamine treatments play a significant role in the downstream value chain.
What are the main activities in the downstream segment of the Mesalamine market in 2025?
The main activities in the downstream segment involve marketing, sales, and distribution of Mesalamine products to end users. Healthcare providers diagnose and prescribe the drug, while pharmacies and hospitals dispense it. Patient education and support services also play an important role in ensuring the proper use of the medication.
How do regulations impact the downstream processes in the Mesalamine market in 2025?
Regulations affect downstream processes through drug approval and safety monitoring, which ensure that Mesalamine is safe and effective for patient use. Additionally, reimbursement policies and insurance regulations can impact how patients access and afford Mesalamine. These regulations can also influence how healthcare providers prescribe the drug.
What challenges do companies face in the downstream processes of the Mesalamine market in 2025?
Companies face challenges such as market competition from generics, increasing pressure from healthcare cost containment measures, and the need to ensure proper patient adherence to treatment regimens. Distribution challenges, particularly in rural or underserved areas, may also hinder the timely delivery of Mesalamine to patients.
How does technology impact the downstream processes in the Mesalamine market in 2025?
Technology impacts the downstream processes by enabling better patient management tools, such as electronic prescriptions and telemedicine services, which improve access to Mesalamine. Additionally, digital platforms and mobile apps help patients track their medication adherence, while data analytics can optimize inventory management for pharmacies and healthcare providers.
Chapter 1, to describe Mesalamine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mesalamine, with price, sales, revenue and global market share of Mesalamine from 2018 to 2023.
Chapter 3, the Mesalamine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mesalamine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Mesalamine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mesalamine.
Chapter 14 and 15, to describe Mesalamine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Mesalamine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Mesalamine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity ≥ 97%
1.3.3 Purity ≥ 98%
1.3.4 Purity ≥ 99%
1.4 Market Analysis by Application
1.4.1 Overview: Global Mesalamine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Mesalazine Tablets
1.4.3 Mesalazine Capsules
1.4.4 Others
1.5 Global Mesalamine Market Size & Forecast
1.5.1 Global Mesalamine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Mesalamine Sales Quantity (2018-2029)
1.5.3 Global Mesalamine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Syntese A/S
2.1.1 Syntese A/S Details
2.1.2 Syntese A/S Major Business
2.1.3 Syntese A/S Mesalamine Product and Services
2.1.4 Syntese A/S Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Syntese A/S Recent Developments/Updates
2.2 Divis Laboratories
2.2.1 Divis Laboratories Details
2.2.2 Divis Laboratories Major Business
2.2.3 Divis Laboratories Mesalamine Product and Services
2.2.4 Divis Laboratories Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Divis Laboratories Recent Developments/Updates
2.3 Cambrex Corporation
2.3.1 Cambrex Corporation Details
2.3.2 Cambrex Corporation Major Business
2.3.3 Cambrex Corporation Mesalamine Product and Services
2.3.4 Cambrex Corporation Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cambrex Corporation Recent Developments/Updates
2.4 Ipca Laboratories
2.4.1 Ipca Laboratories Details
2.4.2 Ipca Laboratories Major Business
2.4.3 Ipca Laboratories Mesalamine Product and Services
2.4.4 Ipca Laboratories Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ipca Laboratories Recent Developments/Updates
2.5 Hangzhou Brother
2.5.1 Hangzhou Brother Details
2.5.2 Hangzhou Brother Major Business
2.5.3 Hangzhou Brother Mesalamine Product and Services
2.5.4 Hangzhou Brother Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hangzhou Brother Recent Developments/Updates
2.6 PharmaZell
2.6.1 PharmaZell Details
2.6.2 PharmaZell Major Business
2.6.3 PharmaZell Mesalamine Product and Services
2.6.4 PharmaZell Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 PharmaZell Recent Developments/Updates
2.7 Lianyungang Fengheng Biopharm
2.7.1 Lianyungang Fengheng Biopharm Details
2.7.2 Lianyungang Fengheng Biopharm Major Business
2.7.3 Lianyungang Fengheng Biopharm Mesalamine Product and Services
2.7.4 Lianyungang Fengheng Biopharm Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
2.8 Lasa Loboratory
2.8.1 Lasa Loboratory Details
2.8.2 Lasa Loboratory Major Business
2.8.3 Lasa Loboratory Mesalamine Product and Services
2.8.4 Lasa Loboratory Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Lasa Loboratory Recent Developments/Updates
2.9 Erregierre SpA
2.9.1 Erregierre SpA Details
2.9.2 Erregierre SpA Major Business
2.9.3 Erregierre SpA Mesalamine Product and Services
2.9.4 Erregierre SpA Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Erregierre SpA Recent Developments/Updates
2.10 Corden Pharma Bergamo
2.10.1 Corden Pharma Bergamo Details
2.10.2 Corden Pharma Bergamo Major Business
2.10.3 Corden Pharma Bergamo Mesalamine Product and Services
2.10.4 Corden Pharma Bergamo Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Corden Pharma Bergamo Recent Developments/Updates
2.11 CTX Lifescience
2.11.1 CTX Lifescience Details
2.11.2 CTX Lifescience Major Business
2.11.3 CTX Lifescience Mesalamine Product and Services
2.11.4 CTX Lifescience Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CTX Lifescience Recent Developments/Updates
2.12 Ishita Active Pharma Ingredients
2.12.1 Ishita Active Pharma Ingredients Details
2.12.2 Ishita Active Pharma Ingredients Major Business
2.12.3 Ishita Active Pharma Ingredients Mesalamine Product and Services
2.12.4 Ishita Active Pharma Ingredients Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Ishita Active Pharma Ingredients Recent Developments/Updates
2.13 YC Biotech (Jiangsu)
2.13.1 YC Biotech (Jiangsu) Details
2.13.2 YC Biotech (Jiangsu) Major Business
2.13.3 YC Biotech (Jiangsu) Mesalamine Product and Services
2.13.4 YC Biotech (Jiangsu) Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 YC Biotech (Jiangsu) Recent Developments/Updates
2.14 Xinxiang Tianfeng Fine Chemical
2.14.1 Xinxiang Tianfeng Fine Chemical Details
2.14.2 Xinxiang Tianfeng Fine Chemical Major Business
2.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Product and Services
2.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
3 Competitive Environment: Mesalamine by Manufacturer
3.1 Global Mesalamine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Mesalamine Revenue by Manufacturer (2018-2023)
3.3 Global Mesalamine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Mesalamine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Mesalamine Manufacturer Market Share in 2022
3.4.2 Top 6 Mesalamine Manufacturer Market Share in 2022
3.5 Mesalamine Market: Overall Company Footprint Analysis
3.5.1 Mesalamine Market: Region Footprint
3.5.2 Mesalamine Market: Company Product Type Footprint
3.5.3 Mesalamine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Mesalamine Market Size by Region
4.1.1 Global Mesalamine Sales Quantity by Region (2018-2029)
4.1.2 Global Mesalamine Consumption Value by Region (2018-2029)
4.1.3 Global Mesalamine Average Price by Region (2018-2029)
4.2 North America Mesalamine Consumption Value (2018-2029)
4.3 Europe Mesalamine Consumption Value (2018-2029)
4.4 Asia-Pacific Mesalamine Consumption Value (2018-2029)
4.5 South America Mesalamine Consumption Value (2018-2029)
4.6 Middle East and Africa Mesalamine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Mesalamine Sales Quantity by Type (2018-2029)
5.2 Global Mesalamine Consumption Value by Type (2018-2029)
5.3 Global Mesalamine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Mesalamine Sales Quantity by Application (2018-2029)
6.2 Global Mesalamine Consumption Value by Application (2018-2029)
6.3 Global Mesalamine Average Price by Application (2018-2029)
7 North America
7.1 North America Mesalamine Sales Quantity by Type (2018-2029)
7.2 North America Mesalamine Sales Quantity by Application (2018-2029)
7.3 North America Mesalamine Market Size by Country
7.3.1 North America Mesalamine Sales Quantity by Country (2018-2029)
7.3.2 North America Mesalamine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Mesalamine Sales Quantity by Type (2018-2029)
8.2 Europe Mesalamine Sales Quantity by Application (2018-2029)
8.3 Europe Mesalamine Market Size by Country
8.3.1 Europe Mesalamine Sales Quantity by Country (2018-2029)
8.3.2 Europe Mesalamine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Mesalamine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Mesalamine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Mesalamine Market Size by Region
9.3.1 Asia-Pacific Mesalamine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Mesalamine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Mesalamine Sales Quantity by Type (2018-2029)
10.2 South America Mesalamine Sales Quantity by Application (2018-2029)
10.3 South America Mesalamine Market Size by Country
10.3.1 South America Mesalamine Sales Quantity by Country (2018-2029)
10.3.2 South America Mesalamine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Mesalamine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Mesalamine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Mesalamine Market Size by Country
11.3.1 Middle East & Africa Mesalamine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Mesalamine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Mesalamine Market Drivers
12.2 Mesalamine Market Restraints
12.3 Mesalamine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Mesalamine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Mesalamine
13.3 Mesalamine Production Process
13.4 Mesalamine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Mesalamine Typical Distributors
14.3 Mesalamine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Mesalamine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Mesalamine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Syntese A/S Basic Information, Manufacturing Base and Competitors
Table 4. Syntese A/S Major Business
Table 5. Syntese A/S Mesalamine Product and Services
Table 6. Syntese A/S Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Syntese A/S Recent Developments/Updates
Table 8. Divis Laboratories Basic Information, Manufacturing Base and Competitors
Table 9. Divis Laboratories Major Business
Table 10. Divis Laboratories Mesalamine Product and Services
Table 11. Divis Laboratories Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Divis Laboratories Recent Developments/Updates
Table 13. Cambrex Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Cambrex Corporation Major Business
Table 15. Cambrex Corporation Mesalamine Product and Services
Table 16. Cambrex Corporation Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Cambrex Corporation Recent Developments/Updates
Table 18. Ipca Laboratories Basic Information, Manufacturing Base and Competitors
Table 19. Ipca Laboratories Major Business
Table 20. Ipca Laboratories Mesalamine Product and Services
Table 21. Ipca Laboratories Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ipca Laboratories Recent Developments/Updates
Table 23. Hangzhou Brother Basic Information, Manufacturing Base and Competitors
Table 24. Hangzhou Brother Major Business
Table 25. Hangzhou Brother Mesalamine Product and Services
Table 26. Hangzhou Brother Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hangzhou Brother Recent Developments/Updates
Table 28. PharmaZell Basic Information, Manufacturing Base and Competitors
Table 29. PharmaZell Major Business
Table 30. PharmaZell Mesalamine Product and Services
Table 31. PharmaZell Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. PharmaZell Recent Developments/Updates
Table 33. Lianyungang Fengheng Biopharm Basic Information, Manufacturing Base and Competitors
Table 34. Lianyungang Fengheng Biopharm Major Business
Table 35. Lianyungang Fengheng Biopharm Mesalamine Product and Services
Table 36. Lianyungang Fengheng Biopharm Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lianyungang Fengheng Biopharm Recent Developments/Updates
Table 38. Lasa Loboratory Basic Information, Manufacturing Base and Competitors
Table 39. Lasa Loboratory Major Business
Table 40. Lasa Loboratory Mesalamine Product and Services
Table 41. Lasa Loboratory Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Lasa Loboratory Recent Developments/Updates
Table 43. Erregierre SpA Basic Information, Manufacturing Base and Competitors
Table 44. Erregierre SpA Major Business
Table 45. Erregierre SpA Mesalamine Product and Services
Table 46. Erregierre SpA Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Erregierre SpA Recent Developments/Updates
Table 48. Corden Pharma Bergamo Basic Information, Manufacturing Base and Competitors
Table 49. Corden Pharma Bergamo Major Business
Table 50. Corden Pharma Bergamo Mesalamine Product and Services
Table 51. Corden Pharma Bergamo Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Corden Pharma Bergamo Recent Developments/Updates
Table 53. CTX Lifescience Basic Information, Manufacturing Base and Competitors
Table 54. CTX Lifescience Major Business
Table 55. CTX Lifescience Mesalamine Product and Services
Table 56. CTX Lifescience Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CTX Lifescience Recent Developments/Updates
Table 58. Ishita Active Pharma Ingredients Basic Information, Manufacturing Base and Competitors
Table 59. Ishita Active Pharma Ingredients Major Business
Table 60. Ishita Active Pharma Ingredients Mesalamine Product and Services
Table 61. Ishita Active Pharma Ingredients Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Ishita Active Pharma Ingredients Recent Developments/Updates
Table 63. YC Biotech (Jiangsu) Basic Information, Manufacturing Base and Competitors
Table 64. YC Biotech (Jiangsu) Major Business
Table 65. YC Biotech (Jiangsu) Mesalamine Product and Services
Table 66. YC Biotech (Jiangsu) Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. YC Biotech (Jiangsu) Recent Developments/Updates
Table 68. Xinxiang Tianfeng Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 69. Xinxiang Tianfeng Fine Chemical Major Business
Table 70. Xinxiang Tianfeng Fine Chemical Mesalamine Product and Services
Table 71. Xinxiang Tianfeng Fine Chemical Mesalamine Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
Table 73. Global Mesalamine Sales Quantity by Manufacturer (2018-2023) & (MT)
Table 74. Global Mesalamine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Mesalamine Average Price by Manufacturer (2018-2023) & (USD/Kg)
Table 76. Market Position of Manufacturers in Mesalamine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Mesalamine Production Site of Key Manufacturer
Table 78. Mesalamine Market: Company Product Type Footprint
Table 79. Mesalamine Market: Company Product Application Footprint
Table 80. Mesalamine New Market Entrants and Barriers to Market Entry
Table 81. Mesalamine Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Mesalamine Sales Quantity by Region (2018-2023) & (MT)
Table 83. Global Mesalamine Sales Quantity by Region (2024-2029) & (MT)
Table 84. Global Mesalamine Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Mesalamine Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Mesalamine Average Price by Region (2018-2023) & (USD/Kg)
Table 87. Global Mesalamine Average Price by Region (2024-2029) & (USD/Kg)
Table 88. Global Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 89. Global Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 90. Global Mesalamine Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Mesalamine Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Mesalamine Average Price by Type (2018-2023) & (USD/Kg)
Table 93. Global Mesalamine Average Price by Type (2024-2029) & (USD/Kg)
Table 94. Global Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 95. Global Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 96. Global Mesalamine Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Mesalamine Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Mesalamine Average Price by Application (2018-2023) & (USD/Kg)
Table 99. Global Mesalamine Average Price by Application (2024-2029) & (USD/Kg)
Table 100. North America Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 101. North America Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 102. North America Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 103. North America Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 104. North America Mesalamine Sales Quantity by Country (2018-2023) & (MT)
Table 105. North America Mesalamine Sales Quantity by Country (2024-2029) & (MT)
Table 106. North America Mesalamine Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Mesalamine Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 109. Europe Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 110. Europe Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 111. Europe Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 112. Europe Mesalamine Sales Quantity by Country (2018-2023) & (MT)
Table 113. Europe Mesalamine Sales Quantity by Country (2024-2029) & (MT)
Table 114. Europe Mesalamine Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Mesalamine Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 117. Asia-Pacific Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 118. Asia-Pacific Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 119. Asia-Pacific Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 120. Asia-Pacific Mesalamine Sales Quantity by Region (2018-2023) & (MT)
Table 121. Asia-Pacific Mesalamine Sales Quantity by Region (2024-2029) & (MT)
Table 122. Asia-Pacific Mesalamine Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Mesalamine Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 125. South America Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 126. South America Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 127. South America Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 128. South America Mesalamine Sales Quantity by Country (2018-2023) & (MT)
Table 129. South America Mesalamine Sales Quantity by Country (2024-2029) & (MT)
Table 130. South America Mesalamine Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Mesalamine Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Mesalamine Sales Quantity by Type (2018-2023) & (MT)
Table 133. Middle East & Africa Mesalamine Sales Quantity by Type (2024-2029) & (MT)
Table 134. Middle East & Africa Mesalamine Sales Quantity by Application (2018-2023) & (MT)
Table 135. Middle East & Africa Mesalamine Sales Quantity by Application (2024-2029) & (MT)
Table 136. Middle East & Africa Mesalamine Sales Quantity by Region (2018-2023) & (MT)
Table 137. Middle East & Africa Mesalamine Sales Quantity by Region (2024-2029) & (MT)
Table 138. Middle East & Africa Mesalamine Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Mesalamine Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Mesalamine Raw Material
Table 141. Key Manufacturers of Mesalamine Raw Materials
Table 142. Mesalamine Typical Distributors
Table 143. Mesalamine Typical Customers
List of Figures
Figure 1. Mesalamine Picture
Figure 2. Global Mesalamine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Mesalamine Consumption Value Market Share by Type in 2022
Figure 4. Purity ≥ 97% Examples
Figure 5. Purity ≥ 98% Examples
Figure 6. Purity ≥ 99% Examples
Figure 7. Global Mesalamine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Mesalamine Consumption Value Market Share by Application in 2022
Figure 9. Mesalazine Tablets Examples
Figure 10. Mesalazine Capsules Examples
Figure 11. Others Examples
Figure 12. Global Mesalamine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Mesalamine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Mesalamine Sales Quantity (2018-2029) & (MT)
Figure 15. Global Mesalamine Average Price (2018-2029) & (USD/Kg)
Figure 16. Global Mesalamine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Mesalamine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Mesalamine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Mesalamine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Mesalamine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Mesalamine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Mesalamine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Mesalamine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Mesalamine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Mesalamine Average Price by Type (2018-2029) & (USD/Kg)
Figure 31. Global Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Mesalamine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Mesalamine Average Price by Application (2018-2029) & (USD/Kg)
Figure 34. North America Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Mesalamine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Mesalamine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Mesalamine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Mesalamine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Mesalamine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Mesalamine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Mesalamine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Mesalamine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Mesalamine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Mesalamine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Mesalamine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Mesalamine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Mesalamine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Mesalamine Market Drivers
Figure 75. Mesalamine Market Restraints
Figure 76. Mesalamine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Mesalamine in 2022
Figure 79. Manufacturing Process Analysis of Mesalamine
Figure 80. Mesalamine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
